Superworth

Large drugmakers with the lowest EV/EBIT

What the whole business costs (market value plus debt, less cash) against operating profit over the last twelve months, one-off items taken out. As of .

Ranked
46
of 411 large drugmakers we cover
Median
12.3×
Lowest
0.9×
ATNM
Range
0.9× to 141×
median 12.3×
0.9×141×
#CompanyEV/EBITPEOperating marginMarket cap
1ATNMActinium Pharmaceuticals0.9×4.0×n/m$45M
2CRMDCorMedix1.4×2.5×47.0%$420.1M
3SPROSpero Therapeutics1.5×9.5×12.8%$60.6M
4ZVRAZevra Therapeutics3.0×10.9×60.5%$599.8M
5IRWDIronwood Pharmaceuticals3.5×4.5×60.1%$571.7M
6PRGOPERRIGO3.7×n/m−37.7%$2.2B
7ABUSArbutus Biopharma4.7×5.1×82.0%$791.4M
8NATRNatures Sunshine Products5.1×11.9×6.0%$211.5M
9EBSEmergent BioSolutions6.5×n/m−8.6%$330.2M
10NRIXNurix Therapeutics7.2×11.1×41.3%$2.8B
11HRMYHarmony Biosciences7.3×12.3×24.0%$2.2B
12INVAInnoviva7.4×n/m36.9%$1.5B
13QTTBQ32 Bio7.4×n/mn/m$259.3M
14PCRXPacira BioSciences7.6×104×2.7%$1.5B
15INDVIndivior Pharmaceuticals8.2×10.2×40.6%$4.3B
16OGNOrganon9.5×18.2×13.6%$3.6B
17COLLCollegium Pharmaceutical9.5×19.1×19.5%$770.9M
18LFVNLifevantage9.6×14.7×3.3%$73.5M
19ANIPANI Pharmaceuticals10.2×15.0×15.4%$1.6B
20RIGLRigel Pharmaceuticals10.2×n/m31.5%$943.9M
21BHCBausch Health Companies10.5×n/m11.2%$3B
22PAHCPhibro Animal Health11.6×15.9×12.8%$1.6B
23AUPHAurinia Pharmaceuticals11.8×n/m48.6%$2.2B
24AMPHAmphastar Pharmaceuticals12.9×15.9×15.7%$1.1B
25PBYIPuma Biotechnology14.2×19.6×13.2%$525.5M
26PFEPfizer14.7×40.6×21.7%$176B
27PBHPrestige Consumer Healthcare14.8×13.9×26.3%$2.4B
28JAZZJazz Pharmaceuticals16.0×14.7×19.5%$13.9B
29AMRXAmneal Pharmaceuticals18.4×41.7×14.6%$6.5B
30LQDALiquidia21.3×30.1×37.4%$3.7B
31GILDGilead Sciences24.6×n/m−7.6%$212.5B
32AMGNAmgen25.8×29.0×30.0%$252.3B
33BMRNBiomarin Pharmaceutical26.3×155×4.4%$11.1B
34PTCTPTC Therapeutics27.5×n/m12.8%$5.1B
35ABBVAbbVie27.5×49.8×32.2%$511.6B
36ACADAcadia Pharmaceuticals30.6×n/m7.6%$3.5B
37LLYEli Lilly and35.1×46.5×40.3%$1.3T
38BIIBBiogen39.2×44.3×12.3%$37B
39XERSXeris Biopharma54.2×n/m10.9%$1.9B
40LGNDLigand Pharmaceuticals58.4×32.7×32.6%$6.1B
41KNSAKiniksa Pharmaceuticals International65.5×93.6×11.9%$7.1B
42TGTXTG Therapeutics68.7×21.9×17.1%$9.2B
43ALKSAlkermes plc.71.4×118×7.0%$7.5B
44ARQTArcutis Biotherapeutics111×142×7.4%$3.9B
45MNKDMannkind116×n/m2.3%$1.2B
46PTGXProtagonist Therapeutics141×135×20.7%$9B

Not ranked: 298 with a loss over the last year, 15 with not a meaningful number, 1 with a value too high to mean anything. 51 companies whose data behind this number has a caveat are left out until it is checked.

A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.

EV/EBIT for other groups

Other rankings of large drugmakers

The group